Aristides Capital’s Ingevity NGVT Stock Holding History

Aristides Capital’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,221	Closed	-$294K	–	328
2023 Q4	$294K	Buy	+6,221	New	+$258K	0.11%	128

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Aristides Capital's NGVT Position: Q1 2024 in Review

Aristides Capital sold out of Ingevity (NGVT) in Q1 2024, closing a stake of 6,221 shares — an estimated $294K sold.

Aristides Capital first reported a position in NGVT in Q4 2023 and held it in 1 quarter. The position peaked at $294K in Q4 2023. 259 funds tracked by Wall St. Rank hold NGVT as of Q1 2024.

Aristides Capital reported no remaining Ingevity position as of Q1 2024 after selling out during the quarter.
Aristides Capital sold 6,221 Ingevity shares in Q1 2024, an estimated $294K.
Aristides Capital first reported a position in Ingevity in Q4 2023 and held it in 1 quarter.
Aristides Capital's Ingevity position peaked at $294K in Q4 2023.
259 funds tracked by Wall St. Rank held Ingevity as of Q1 2024.

Based on Aristides Capital's 13F filing for Q1 2024, filed 15 May 2024.